Galilei Investment Office’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.52M Buy
56,644
+783
+1% +$47.3K 1.61% 12
2026
Q1
$3.22M Buy
55,861
+713
+1% +$42.2K 1.67% 12
2025
Q4
$3.13M Hold
55,148
– – 1.47% 14
2025
Q3
$2.93M Buy
55,148
+780
+1% +$42.3K 1.41% 14
2025
Q2
$2.58M Buy
54,368
+949
+2% +$42K 1.31% 14
2025
Q1
$2.19M Buy
53,419
+948
+2% +$37.3K 1.19% 16
2024
Q4
$1.89M Buy
+52,471
New +$1.9M 0.96% 19

Other funds holding BTI

Galilei Investment Office's BTI Position: Q2 2026 in Review

Galilei Investment Office increased its British American Tobacco (BTI) stake by 1.4% in Q2 2026, buying an estimated $47.3K and bringing the position to 56,644 shares worth $3.52M. The position accounts for 1.61% of the portfolio, ranked #12.

Galilei Investment Office first reported a position in BTI in Q4 2024 and has held it in 7 quarters since. 910 funds tracked by Wall St. Rank hold BTI as of Q2 2026.

  • Galilei Investment Office held 56,644 shares of British American Tobacco worth $3.52M as of Q2 2026.
  • Galilei Investment Office bought 783 British American Tobacco shares in Q2 2026, an estimated $47.3K.
  • British American Tobacco made up 1.61% of Galilei Investment Office's portfolio in Q2 2026, its #12 holding.
  • Galilei Investment Office first reported a position in British American Tobacco in Q4 2024 and has held it in 7 quarters since.
  • 910 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2026.

Based on Galilei Investment Office's 13F filing for Q2 2026, filed 30 Jul 2026.